close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about DMT Clinical Trial

Recent news which mentions DMT Clinical Trial

Atai's DMT Depression Drug Shows Promise, Prepares For Phase II Trial And Future Collaboration With Pharma Giant
Tickers ATAI
Tags DMT/Assisted Therapy Cannabis Market News
From Benzinga
Cybin Inc's Two Deuterated Psychedelic Molecules Achieve Positive Topline Clinical Results
Tickers CYBN NEWS
Tags Benzinga Management Deuterated Psychedelics
From Benzinga
Cybin Officially Owns Small Pharma: Plans For New 'International Leader' In Psychedelic Therapeutics
Tickers CYBN DMTTF
Tags Markets M&A Psychedelics Research
From Benzinga
Atai Life Sciences Completes Phase 1 Clinical Study Of Oral Film DMT Formulation
Tickers ATAI
Tags Psychedelics News Markets
From Benzinga
Cybin And Fluence Partner To Support EMBARK Training For Phase 3 CYB003 Trial For Depression
Tickers CYBN
Tags Contracts Benzinga Management
From Benzinga
Depression Relief: Possible Therapy Boost With DMT & SSRIs, Per Small Pharma Clinical Results
Tickers CYBN DMTTF
Tags CYBN News Psychedelics
From Benzinga
Cybin's Acquisition Of Small Pharma Will Elevate DMT Therapeutics For Depression And Anxiety
Tickers CYBN DMTTF
Tags DMT Clinical Trial Psychedelic/Assisted Therapies M&A
From Benzinga
Cybin Launches 3-Day Overnight Public Offering For Up To $8.25M, Suspends Prior Purchase Deal
Tickers CYBN IPOS
Tags DMT Clinical Trial Psychedelic/Assisted Therapies Market News
From Benzinga
DMT's Clinical Path For Treating TBI And Stroke: Phase 1 Dosing Finished As Phase 2 Gears Up
Tickers AGNPF
Tags Management Human Stroke Benzinga
From Benzinga
Novel DMT Compound For Anxiety Shows Clinical Progress: Robust Effects Within 2 Minutes
Tickers CYBN
Tags Market News Cannabis CYBN
From Benzinga
Atai Life Sciences Q1 2023 Results, Pipeline Update On DMT And Psilocybin Clinical Trials
Tickers ATAI CMPS
Tags Benzinga Earnings CMPS
From Benzinga
This IV Psychedelic-Based Compound Completes Phase 2a Trial, Company Gets Extra IP Coverage
Tickers DMTTF
Tags Benzinga DMT Clinical Trial Psychedelic/Assisted Therapies
From Benzinga
Psychedelic Therapeutics For Human Stroke: Participant Screening Expects To Begin Soon
Tickers AGNPF
Tags Benzinga DMT Clinical Trial Psychedelics Therapy
From Benzinga
Next-Gen Psychedelic Delivers Promising Results For Treatment-Resistant Depression In Phase 2 Clinical Trial
Tickers BMNDF
Tags Psychedelics Markets Drug Delivery Technologies
From Benzinga
Tackling Depression With Psychedelics: New Phase 2 Clinical Study Begins At Yale University
Tickers AGNPF
Tags Cannabis Penny Stocks AGNPF
From Benzinga
atai's Phase 1 Synthetic DMT-Based Drug Clinical Trial Begins Patient Dosing
Tickers ATAI
Tags treatment/resistant depression ATAI Small Cap
From Benzinga
Clinical Study On DMT Inhaled Product For Treatment-Resistant Depression Completes Dosing Stage
Tickers BMNDF
Tags DMT Clinical Trial Markets Penny Stocks
From Benzinga
A Deeper Look At DMT Trials & Studies
Tickers DMT
Tags Psychedelics contributors Markets
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at /week.